Here are three things to know about Ms. Rometty’s departure:
1. She initially joined IBM in October 2015 as VP and general manager of global markets for Watson Health, before assuming her current role in January 2018.
2. The spokesperson confirmed Ms. Rometty is leaving the company to pursue another, unspecified opportunity elsewhere. Prior to IBM, she held executive roles at GE Capital and Baxter International.
3. The shake-up comes not long after Deborah DiSanzo stepped down as head of Watson Health in October 2018, amid growing concerns about the efficacy of the Watson for Oncology artificial intelligence platform.
More articles about AI:
Dell, Microsoft throw millions behind AI startups to ‘get a window on innovation’
Texas hospital uses AI for stroke care: 3 notes
Former member of Google’s disbanded AI ethics team leaves the company
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
